HESG — Health Sciences Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $3.49m
- $0.36m
Annual income statement for Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2004 December 31st | 2005 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 8-K | 8-K | 8-K |
Standards: | USG | USG | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.067 | 0.06 | 0.174 | 0.197 | 0.358 |
Cost of Revenue | |||||
Gross Profit | 0.046 | 0.023 | 0.046 | 0.066 | 0.084 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.61 | 7.98 | 0.274 | 0.264 | 0.413 |
Operating Profit | -5.54 | -7.92 | -0.099 | -0.066 | -0.054 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.44 | -5.58 | -0.099 | -0.066 | -0.054 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.44 | -5.58 | -0.099 | -0.066 | -0.054 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -10.4 | -5.75 | -0.099 | -0.066 | -0.054 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -11 | -6.09 | -0.099 | -0.066 | -0.054 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.351 | -0.223 | -0 | 0 | 0 |
Dividends per Share |